Devonian Health Group Inc. (TSXV: GSD)
Canada
· Delayed Price · Currency is CAD 0.155
+0.025 (19.23%)
Jan 21, 2025, 4:00 PM EST
Devonian Health Group Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2019 - 2015 |
| Revenue | 22.39 | 17.82 | 2.35 | 2.31 | 1.47 | 2.14 | Upgrade
|
| Revenue Growth (YoY) | 598.16% | 659.60% | 1.74% | 56.32% | -31.19% | -46.49% | Upgrade
|
| Cost of Revenue | 15.21 | 11.83 | 1.45 | 1.74 | 1.72 | 2.21 | Upgrade
|
| Gross Profit | 7.18 | 5.99 | 0.89 | 0.56 | -0.24 | -0.07 | Upgrade
|
| Selling, General & Admin | 6.19 | 5.44 | 3.75 | 2.58 | 1.45 | 2.48 | Upgrade
|
| Research & Development | 1.41 | 1.29 | 1.35 | 0.78 | 0.61 | 1.54 | Upgrade
|
| Other Operating Expenses | 0.12 | 0.12 | 0.12 | 0.11 | - | - | Upgrade
|
| Operating Expenses | 7.72 | 6.85 | 5.22 | 3.47 | 2.07 | 4.02 | Upgrade
|
| Operating Income | -0.54 | -0.86 | -4.32 | -2.91 | -2.31 | -4.09 | Upgrade
|
| Interest Expense | -0.35 | -0.38 | -0.46 | -0.94 | -0.79 | -0.76 | Upgrade
|
| Interest & Investment Income | 0.12 | 0.07 | 0.18 | 0.04 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | -0.06 | - | 0.36 | -0.29 | 0.47 | Upgrade
|
| EBT Excluding Unusual Items | -0.86 | -1.22 | -4.6 | -3.45 | -3.39 | -4.37 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.05 | - | Upgrade
|
| Pretax Income | -0.86 | -1.22 | -4.6 | -3.45 | -3.35 | -4.37 | Upgrade
|
| Net Income | -0.86 | -1.22 | -4.6 | -3.45 | -3.35 | -4.37 | Upgrade
|
| Net Income to Common | -0.86 | -1.22 | -4.6 | -3.45 | -3.35 | -4.37 | Upgrade
|
| Shares Outstanding (Basic) | 148 | 147 | 136 | 119 | 89 | 72 | Upgrade
|
| Shares Outstanding (Diluted) | 148 | 147 | 136 | 119 | 89 | 72 | Upgrade
|
| Shares Change (YoY) | 6.04% | 8.51% | 13.89% | 33.98% | 22.70% | 7.38% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.03 | -0.03 | -0.04 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.03 | -0.03 | -0.04 | -0.06 | Upgrade
|
| Free Cash Flow | 8.84 | 5.63 | -4.36 | -2.95 | -1.83 | -2.03 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.04 | -0.03 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 32.06% | 33.62% | 38.05% | 24.34% | -16.34% | -3.27% | Upgrade
|
| Operating Margin | -2.42% | -4.82% | -184.37% | -126.35% | -156.37% | -190.61% | Upgrade
|
| Profit Margin | -3.86% | -6.87% | -196.11% | -149.59% | -226.92% | -204.13% | Upgrade
|
| Free Cash Flow Margin | 39.48% | 31.60% | -185.74% | -127.77% | -124.32% | -94.61% | Upgrade
|
| EBITDA | 0.08 | -0.22 | -3.92 | -2.07 | -1.3 | -3.06 | Upgrade
|
| EBITDA Margin | 0.35% | -1.24% | -167.35% | -89.81% | -87.87% | -142.90% | Upgrade
|
| D&A For EBITDA | 0.62 | 0.64 | 0.4 | 0.84 | 1.01 | 1.02 | Upgrade
|
| EBIT | -0.54 | -0.86 | -4.32 | -2.91 | -2.31 | -4.09 | Upgrade
|
| EBIT Margin | -2.42% | -4.82% | -184.37% | -126.35% | -156.37% | -190.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.